| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |